An observational study in Pituitary Disease, Pituitary Incidentaloma and Acromegaly, sponsored by Seoul National University Hospital. Status unknown at 1 site in Korea, Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-18.
Sponsored by Seoul National University Hospital · Observational
The purpose of this study is to investigate the treatment and natural history of pituitary disease. We have a longstanding interest in pituitary disease including acromegaly, central diabetes insipidus, and nonfunctioning pituitary adenoma. We will continue to follow patients and recruit new patients for treatment and follow-up. Blood and pituitary tumor tissue (when available through clinical care) will be saved for future analyses related to pituitary disease.
Subjects for this study will be recruited if they are:
74 studies on the registry are indexed under Pituitary Diseases; 15 are open to participants now.
This study's planned enrollment of 1,600 is above the median of 292 across 31 observational studies indexed under Pituitary Diseases.
Browse Pituitary Diseases studies →Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients diagnosed with pituitary disease at Seoul National University Hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Subjects for this study will be recruited if they are:
Exclusion Criteria:
Patients diagnosed with acromegaly
Other: Dynamic hormone study and Magnetic resonance imaging
Patients diagnosed with Cushing's disease
Other: Dynamic hormone study and Magnetic resonance imaging
Patients diagnosed with hyperprolactinemia/prolactinoma
Other: Dynamic hormone study and Magnetic resonance imaging
Patients diagnosed with pituitary stalk lesions
Other: Dynamic hormone study and Magnetic resonance imaging
Patients diagnosed with nonfunctioning pituitary adenomas
Other: Dynamic hormone study and Magnetic resonance imaging
Patients diagnosed with central diabetes insipidus
Other: Dynamic hormone study and Magnetic resonance imaging
Patients diagnosed with craniopharyngiomas
Other: Dynamic hormone study and Magnetic resonance imaging
Patients diagnosed with other suprasellar/parasellar lesions
Other: Dynamic hormone study and Magnetic resonance imaging
1. Medical history 2. Imaging examination including brain magnetic resonance imaging 3. Blood (Basal hormone study and follow-up study) and pituitary tumor tissue
Treatment outcome of pituitary diseases
Remission rate
Time frame: Up to 10 years
Complications of pituitary disease
Visual field defect or hypopituitarism, hormone hyperfunction-related complications
Time frame: Up to 10 years
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital →